| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5604797 | International Journal of Cardiology | 2017 | 7 Pages |
Abstract
This study highlights the limitations of Nt-proBNP in AS and raises caution regarding its use, at least as a single factor, in the decision-making process regarding asymptomatic patients with AS.
Keywords
TTENYHAMPGLVEFNT-proBNPAVAROCBNPARBACEAUCAngiotensin-converting enzymeNew York Heart Associationstandard deviationTransthoracic echocardiographyleft ventriclecoronary artery diseaseAortic stenosisAortic valve stenosisPeak velocitybody mass indexBMIMean pressure gradientCorrelation coefficientCADAtrial fibrillationangiotensin II receptor blockerarea under the curveaortic valve areareceiver operator characteristicbrain natriuretic peptidenatriuretic peptidesprognosisleft ventricular ejection fraction
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Virginia Nguyen, Claire Cimadevilla, Dimitri Arangalage, Monique Dehoux, Isabelle Codogno, Xavier Duval, Sarah Tubiana, Alec Vahanian, David Messika-Zeitoun,